Title:
PHARMACEUTICAL COMPOSITION FOR PROMOTING OSTEOGENESIS, COMPRISING OSTEOBLAST-DERIVED MITOCHONDRIA
Document Type and Number:
WIPO Patent Application WO/2020/242250
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for promoting osteogenesis and a pharmaceutical composition for treating bone diseases, the compositions comprising osteoblast-derived mitochondria as an active ingredient.
More Like This:
Inventors:
LEE YUNSIL (KR)
KIM NAKYUNG (KR)
SUH JOONHO (KR)
KIM NAKYUNG (KR)
SUH JOONHO (KR)
Application Number:
PCT/KR2020/007015
Publication Date:
December 03, 2020
Filing Date:
May 29, 2020
Export Citation:
Assignee:
SEOUL NAT UNIV R&DB FOUNDATION (KR)
International Classes:
A61K35/32; A01K67/027; A61P19/08; C12N5/077
Domestic Patent References:
WO2008137035A1 | 2008-11-13 |
Foreign References:
KR20180071030A | 2018-06-27 | |||
KR20150093640A | 2015-08-18 | |||
KR20180054522A | 2018-05-24 |
Other References:
KALANI, ANURADHA, KAMAT PRADIP K., VOOR MICHAEL J., TYAGI SURESH C., TYAGI NEETU: "Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia", MOL. CELL BIOCHEM, vol. 295, 18 June 2014 (2014-06-18), pages 89 - 98, XP055764739, DOI: 10.1007/s11010-014-2114-3
Attorney, Agent or Firm:
YOU ME PATENT AND LAW FIRM (KR)
Download PDF: